Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 2947-2954

  Vallejo, Abbe N ^a   Mügge, Lars O ^a,b   Klimiuk, Piotr A ^a,c   Weyand, Cornelia M ^a   Goronzy, Jörg J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CD47 ANTIGEN; THROMBOSPONDIN 1;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CHEMOTAXIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0343484319     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.2947     Document Type: Article

References (54)

1. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104.
2. Harding, C. V., and E. R. Unanue. 1990. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 346: 574.
3. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell co-stimulation. Annu. Rev. Immunol. 14:233.
4. + T cell response. Crit. Rev. Immunol. 17:89.
5. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell co-stimulatory requirements in CD28-deficient mice. Science 261:609.
6. Schweitzer, A. N., and A. H. Sharpe. 1998. Studies using antigen presenting cells lacking of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J. Immunol. 161:2762.
7. Gause, W. C., S. J. Chen, R. J. Greenwald, M. J. Halvorson, P. Lu, X. D. Zhou, S. C. Morris, K. P. Lee, C. H. June, F. D. Finkelman, et al. 1997. CD28 dependence of T cell differentiation to IL4 production varies with particular type 2 immune response. J. Immunol. 158:4082.
8. Kawai, K., A. Shahinian, T. W. Mak, and P. S. Ohashi. 1996. Skin allograft rejection in CD28-deficient mice. Transplantation 61:352.
9. Watts, T. H., and M. A. DeBenedette. 1999. T cell costimulatory molecules other than CD28. Curr. Opin. Immunol. 11:286.
10. + CD7 CD28 T cells are expanded in rheumatoid arthritis and are characterized by auto-reactiv-ity. J. Clin. Invest. 97:2027.
11. Liuzzo, G. S. L. Kopecky, R. L. Frye, A. Maseri, J. J. Goronzy, and C. M. Weyand. 1999. Perturbation of the T cell repertoire in patients with unstable angina. Circulation 100:2135.
12. Moosig, F., E. Csernok, G. Wang, and W. L. Gross. 1998. Costimulatory molecules in Wegener's granulumatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin. Exp. Immunol. 114:113.
13. Dutra, W. O., O. A. Martins-Filho, J. R. Cancado, J. C. Pinto-Dias, Z. Brener, G. Gazzinelli, J. F. Carvalho, and D. G. Colley. 1996. Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand. J. Immunol. 43:88.
14. + T cells down-regulates the expression of CD28: effect on T cell activation and cytokine production. Clin. Immunol. Immunopathol. 77:262.
15. + T cells is associated with the loss of gene-specific nuclear factor binding activity. J. Biol. Chem. 273:8119.
16. Vallejo, A. N., J. C. Brandes, C. M. Weyand, and J. J. Goronzy. 1999. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senesence. J. Immunol. 162:6572.
17. + CD28 T cells. Eur. J. Immunol. 27:1082.
18. - T cells from rheumatoid arthritis patients. J. Immunol. 161:1018.
19. Weyand, C. M., and J. J. Goronzy. 1999. T-cell responses in rheumatoid arthritis: systemic abnormalities-local disease. Curr. Opin. Rheumatol. 11:210.
20. th Ed. W. J. Koopman, ed. Williams and Wilkins, Baltimore, MD. p. 993.
21. Haynes, B. F., B. J. Grover, L. P. Whichard, L. P. Hale, J. A. Nunley, D. E. McCollum, and K. H. Singer. 1988. Synovial microenvironment-T cell interactions: human T cells bind to fibroblast-like synovial cells in vitro. Arthritis Rheum. 31:947.
22. 1 integrin-mediated interaction with extracellular matrix proteins regulates cytokine gene expression in synovial fluid cells of rheumatoid arthritis patients. J. Exp. Med. 177:863.
23. Lahav, J. 1993. The functions of thrombospondin and its involvement in physiology and pathophysiology. Biochim. Biophys. Acta 1182:1.
24. Koch, A. E., J. Freidman, J. C. Burrows, G. K. Haines, and N. P. Bouck. 1993. Localization of the angiogenesis inhibitor thrombospondin in human synovial tissue. Pathobiology 61:1.
25. 1 (VLA-5) integrins. J. Immunol. 151:149.
26. Gao, A. G., F. P. Lindberg, M. B. Finn, S. D. Blystone, E. J. Brown, and W. A. Frazier. 1996. Integrin-associated protein is a receptor for the COOH-terminal domain of thrombospondin. J. Biol. Chem. 271:21.
27. Reinhold, M. I., F. P. Lindberg, G. J. Kersch, P. M. Allen, and E. J. Brown. 1997. Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent. CD28-independent signaling pathway. J. Exp. Med. 185:1.
28. Ticchioni, M., M. Deckert, F. Mary, G. Bernard, E. J. Brown, and A. Bernard. 1997. Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells. J. Immunol. 158:677.
29. Gresham, H. D., J. L. Goodwin, D. C. Anderson, and E. J. Brown. 1989. A novel member of the integrin receptor family mediates Arg-Gly-Asp stimulated neutrophil phagocytosis. J. Cell Biol. 108:1935.
30. Brown, E. J., L. Hooper, T. Ho, and H. D. Gresham. 1990. Integrin-associated protein: a 50 kD plasma membrane antigen physically and functionally associated with integrins. J. Cell Biol. 111:2785.
31. 3 function through integrin-associated protein. J. Cell Biol. 135:533.
32. 3dependent ligand binding. J. Cell Biol. 123:485.
33. Tuszynski, G. P., V. Rothman, A. Murphy, K. Siegler, L. Smith, S. Smith, J. Karczewski, and K. A. Knudsen. 1987. Thrombospondin promotes cell-substratum adhesion. Science 236:1570.
34. Majack, R. A., S. C. Cook, and P. Bornstein. 1986. Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Proc. Nat. Acad. Sci. USA 83:9050.
35. Asch, A. S., S. Silbiger, E. Heimer, and R. L. Nachman. 1992. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem. Biophys. Res. Commun. 182:1208.
36. Lyons, D. S., S. A. Lieberman, J. Hampl, J. J. Boniface, Y. Chien, L. J. Berg, and M. M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5:53.
37. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signaling: altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy. Cell 79:913.
38. Lee, D. S., C. Ahn, B. Ernst, J. Sprent, and C. D. Surh. 1999. Thymic selection by a single MHC/peptide ligand: autoreactive T cells are low-affinity cells. Immunity 10:83.
39. Speiser, D. E., M. F. Bachmann, A. Shahinian, T. W. Mak, and P. S. Ohashi. 1997. Acute graft-versus-host disease without costimulation via CD28. Transplantation 63:1042.
40. Wen, T., K. Kono, A. Shahinian, R. Keissling, T. W. Mak, and G. Klein. 1997. CD28 is not required for rejection of unmanipulated syngeneic and autologous tumors. Eur. J. Immunol. 27:1988.
41. Frazier, W. A., A. G. Gao, J. Dimitry, J. Chung, E. J. Brown, F. P. Lindberg, and M. E. Linder. 1999. The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi. J. Biol. Chem. 274:8554.
42. 1 integrin and proteoglycan mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin peptides. J. Immunol. 163:3621.
43. Rudd, C. E. 1996. Upstream-downstream: CD28 cosignaling pathways and T cell function. Immunity 4:527.
44. Lu, Y., B. Cuevas, S. Gibson, H. Khan, R. LaPushin, J. Imboden, and G. B. Mills. 1998. Phosphatidylinositol 3-kinase is required for CD28 but not CD3 regulation of the TEC family tyrosine kinasc EMT/ITK/TSK: functional and physical interaction of EMT with phosphatidylinositol 3-kinase. J. Immunol. 161:5404.
45. Kuchroo, V. K., M. P. Das, J. A., Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
46. Larche, M., S. J. Till, B. M. Haselden, J. North, J. Barkans, C. J. Corrigan, A. B. Kay, and D. S. Robinson. 1998. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J. Immunol. 161:6375.
47. Elloso, M. M., and P. Scott. 1999. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection. J. Immunol. 162:6708.
48. Slavik, J. M., J. E. Hutchcroft, and B. E. Bierer. 1999. CD80 and CD86 are not equivalent in their ability to induce tyrosine phosphorylation of CD28. J. Biol. Chem. 274:3116.
49. Chin, J. E., G. E. Winterrowd, R. F. Krzesicki, and M. E. Sanders. 1990. Role of cytokines in inflammatory synovitis: the coordinate regulation of intercellular adhesion molecule 1 and HLA class I and class II antigens in rheumatoid synovial fibroblasts. Arthritis Rheum. 33:1776.
50. Li, Y., G. R. Sun, J. R. Tumang, M. K. Crow, and S. M. Friedman. 1994. CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells: evidence for an antigen-driven response. J. Clin. Invest. 94:2525.
51. Volpes, R., J. J. van den Oord, and V. J. Desmet. 1990. Adhesive molecules in liver disease: immunohistochemical distribution of thrombospondin receptors in chronic HBV infection. J. Hepatol. 10:297.
52. McGregor, B., S. Colon, M. Mutin, E. Chignier, P. Zech, and J. McGregor. 1994. Thrombospondin in human glomerulopathies: a marker of inflammation and early flibrosis. Am. J. Pathol. 144:1281.
53. Roth, J. J., V. Gahtan, J. L. Brown, C. Gerhard, V. K. Swami, V. L. Rothman, T. N. Tulenko, and G. P. Tuszynski. 1998. Thrombospondin-1 is elevated with both intimal hyperplasia and hypercholesterolemia. J. Surg. Res. 74:11.
54. El-Youssef, M., Y. Mu, L. Huang, V. Stellmach, and S. E. Crawford. 1999. Increased expression of transforming growth factor-β1 and thrombospondin-1 in congenital hepatic fibrosis: possible role of the hepatic stellate cell. J. Pediatr. Gastroenterol. Nutr. 28:386.